Disclosure 0000905148-26-004080-3

SEC FORM 4

$11,594.00

RIGEL PHARMACEUTICALS INC (RIGL)

Acquisition (code M) of 620 shares at $18.7 per share.

Reporting Person Schorno Dean L · Officer Title EVP & Chief Financial Officer · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0000905148-26-004080 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "RIGEL PHARMACEUTICALS INC (RIGL)." Disclosed 2026-09-03. https://desqlong.com/cards/0000905148-26-004080-3 (retrieved 2026-09-26).